Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2013

Feb 13, 2013

30583_dirs_2013-02-13_c00b998c-40d9-4b79-98ac-3625aa135a01.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-05-12

Reporting Person: Wood Mark (VP, Human Resources)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-05-12 Common Stock F 1589 $38.00 Disposed 23116 Direct
2012-06-06 Common Stock F 459 $37.99 Disposed 22657 Direct
2012-10-31 Common Stock P 588 $27.9055 Acquired 23245 Direct

Footnotes

F1: The reporting person is reporting the acquisition of shares of the issuer's Employee Stock Purchase Program ("ESPP"), for the ESPP purchase period of May 1, 2012 to October 31, 2012.